Radium-223 and concomitant therapies in patients with metastatic castration-resistant prostate cancer: an international, early access, open-label, single-arm phase 3b trial by Saad, Fred, Prof, Carles, Joan, MD, Gillessen, Silke, Prof, Heidenreich, Axel, Prof, Heinrich, Daniel, MD, Gratt, Jeremy, BA, Lévy, Jérémy, ScD, Miller, Kurt, Prof, Nilsson, Sten, Prof, Petrenciuc, Oana, MD, Tucci, Marcello, MD, Wirth, Manfred, Prof, Federhofer, Judith, MD, O'Sullivan, Joe M, Prof

Get full text

Chemotherapy following radium-223 dichloride treatment in ALSYMPCA by Sartor, Oliver, Hoskin, Peter, Coleman, Robert E., Nilsson, Sten, Vogelzang, Nicholas J., Petrenciuc, Oana, Staudacher, Karin, Thuresson, Marcus, Parker, Christopher

Get full text

Phase I Trial of Sorafenib and Gemcitabine in Advanced Solid Tumors with an Expanded Cohort in Advanced Pancreatic Cancer by SIU, Lillian L, AWADA, Ahmad, TAKIMOTO, Chris H, PICCART, Martine, SCHWARTZ, Brian, GIANNARIS, Tom, LATHIA, Chetan, PETRENCIUC, Oana, MOORE, Malcolm J

Get full text

A Phase I Trial of the Oral, Multikinase Inhibitor Sorafenib in Combination with Carboplatin and Paclitaxel by Flaherty, Keith T, Schiller, Joan, Schuchter, Lynn M, Liu, Glenn, Tuveson, David A, Redlinger, Maryann, Lathia, Chetan, Xia, Chenghua, Petrenciuc, Oana, Hingorani, Sunil R, Jacobetz, Michael A, Van Belle, Patricia A, Elder, David, Brose, Marcia S, Weber, Barbara L, Albertini, Mark R, O'Dwyer, Peter J

Get full text

Three-year Safety of Radium-223 Dichloride in Patients with Castration-resistant Prostate Cancer and Symptomatic Bone Metastases from Phase 3 Randomized Alpharadin in Symptomatic P... by Parker, Christopher C., Coleman, Robert E., Sartor, Oliver, Vogelzang, Nicholas J., Bottomley, David, Heinrich, Daniel, Helle, Svein I., O'Sullivan, Joe M., Fosså, Sophie D., Chodacki, Aleš, Wiechno, Paweł, Logue, John, Seke, Mihalj, Widmark, Anders, Johannessen, Dag Clement, Hoskin, Peter, James, Nicholas D., Solberg, Arne, Syndikus, Isabel, Kliment, Jan, Wedel, Steffen, Boehmer, Sibylle, Dall’Oglio, Marcos, Franzén, Lars, Bruland, Øyvind S., Petrenciuc, Oana, Staudacher, Karin, Li, Rui, Nilsson, Sten

Get full text

Radium-223 in combination with docetaxel in patients with castration-resistant prostate cancer and bone metastases: a phase 1 dose escalation/randomised phase 2a trial by Morris, Michael J., Loriot, Yohann, Sweeney, Christopher J., Fizazi, Karim, Ryan, Charles J., Shevrin, Daniel H., Antonarakis, Emmanuel S., Pandit-Taskar, Neeta, Deandreis, Désirée, Jacene, Heather A., Vesselle, Hubert, Petrenciuc, Oana, Lu, Cindy, Carrasquillo, Jorge A., Higano, Celestia S.

Get full text

Evaluation of Clinically Relevant Drug–Drug Interactions and Population Pharmacokinetics of Darolutamide in Patients with Nonmetastatic Castration-Resistant Prostate Cancer: Result... by Shore, Neal, Zurth, Christian, Fricke, Robert, Gieschen, Hille, Graudenz, Kristina, Koskinen, Mikko, Ploeger, Bart, Moss, Jonathan, Prien, Olaf, Borghesi, Gustavo, Petrenciuc, Oana, Tammela, Teuvo L., Kuss, Iris, Verholen, Frank, Smith, Matthew R., Fizazi, Karim

Get full text

Radium‐223 Safety, Efficacy, and Concurrent Use with Abiraterone or Enzalutamide: First U.S. Experience from an Expanded Access Program by Sartor, Oliver, Vogelzang, Nicholas J., Sweeney, Christopher, Fernandez, Daniel C., Almeida, Fabio, Iagaru, Andrei, Brown, Alan, Smith, Matthew R., Agrawal, Manish, Dicker, Adam P., Garcia, Jorge A., Lutzky, Jose, Wong, Yu‐Ning, Petrenciuc, Oana, Gratt, Jeremy, Shore, Neal D., Morris, Michael J.

Get full text

A randomized phase II trial of maintenance therapy with Sorafenib in front-line ovarian carcinoma by Herzog, Thomas J, Scambia, Giovanni, Kim, Byoung-Gie, Lhommé, Catherine, Markowska, Janina, Ray-Coquard, Isabelle, Sehouli, Jalid, Colombo, Nicoletta, Shan, Minghua, Petrenciuc, Oana, Oza, Amit

Get full text

A phase 3 tRial comparing capecitabinE in combination with SorafenIb or pLacebo for treatment of locally advanced or metastatIc HER2-Negative breast CancEr (the RESILIENCE study):... by Baselga, José, Costa, Frederico, Gomez, Henry, Hudis, Clifford A, Rapoport, Bernardo, Roche, Henri, Schwartzberg, Lee S, Petrenciuc, Oana, Shan, Minghua, Gradishar, William J

Get full text

Abstract C23: Phase 3 trial comparing capecitabine in combination with sorafenib or placebo for treatment of locally advanced or metastatic HER2-negative breast cancer (RESILIENCE) by Baselga, Jose, Costa, Frederico, Gomez, Henry, Hudis, Clifford, Rapoport, Bernardo, Roche, Henri, Schwartzberg, Lee S., Petrenciuc, Oana, Shan, Minghua, Gradishar, William J.

Get full text

Phase I and pharmacokinetic study of Bay 38-3441, a camptothecin glycoconjugate, administered as a 30-minute infusion daily for five days every 3 weeks in patients with advanced so... by Chen, Eric X, Batist, Gerald, Siu, Lillian L, Bangash, Naeema, Maclean, Martha, McIntosh, Lynn, Miller, Jr, Wilson H, Oza, Amit M, Lathia, Chetan, Petrenciuc, Oana, Seymour, Lesley

Get full text